K Park

1.1k total citations
14 papers, 797 citations indexed

About

K Park is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, K Park has authored 14 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 3 papers in Cancer Research. Recurrent topics in K Park's work include Colorectal Cancer Treatments and Studies (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). K Park is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). K Park collaborates with scholars based in South Korea, United States and Japan. K Park's co-authors include Jennifer Bryant, Elizabeth Tan-Chiu, Roger P. Smith, A Brown, Soonmyung Paik, Norman Wolmark, Edward H. Romond, D. Lawrence Wickerham, Greg Yothers and W. Douglas B. Hiller and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, European Heart Journal and British Journal of Cancer.

In The Last Decade

K Park

11 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Park South Korea 6 648 248 228 201 180 14 797
Hyesil Seol South Korea 15 480 0.7× 207 0.8× 244 1.1× 123 0.6× 264 1.5× 34 853
Dara S. Ross United States 18 725 1.1× 361 1.5× 388 1.7× 183 0.9× 272 1.5× 58 1.2k
Alice E. Guardino United States 9 477 0.7× 226 0.9× 114 0.5× 128 0.6× 124 0.7× 13 745
Robert B. Jenkins United States 5 734 1.1× 325 1.3× 222 1.0× 150 0.7× 215 1.2× 8 1.1k
Aude Lamy France 14 499 0.8× 196 0.8× 223 1.0× 162 0.8× 364 2.0× 28 931
Anna Cardillo Italy 17 734 1.1× 151 0.6× 173 0.8× 211 1.0× 252 1.4× 29 1.1k
Genevive Hernandez United States 12 624 1.0× 121 0.5× 121 0.5× 241 1.2× 180 1.0× 26 752
Merdol Ibrahim United Kingdom 15 469 0.7× 262 1.1× 146 0.6× 86 0.4× 254 1.4× 19 735
Antonio Durando Italy 16 516 0.8× 108 0.4× 158 0.7× 137 0.7× 318 1.8× 42 976
Chikako Shimizu Japan 17 626 1.0× 118 0.5× 166 0.7× 205 1.0× 157 0.9× 53 975

Countries citing papers authored by K Park

Since Specialization
Citations

This map shows the geographic impact of K Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Park more than expected).

Fields of papers citing papers by K Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Park. The network helps show where K Park may publish in the future.

Co-authorship network of co-authors of K Park

This figure shows the co-authorship network connecting the top 25 collaborators of K Park. A scholar is included among the top collaborators of K Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Park. K Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Park, K, Yikyung Park, Hae‐Jeong Park, Eunice You, & Y Kim. (2023). A-204 Associations between Apolipoprotein B/A1 Ratio, Lipoprotein(a) and the Risk of Metabolic-associated Fatty liver Diseases in a Korean Population. Clinical Chemistry. 69(Supplement_1).
2.
Park, K, et al.. (2023). Comparison study of olmesartan and valsartan on myocardial metabolism in patients with dilated cardiomyopathy trial. European Heart Journal. 44(Supplement_2). 1 indexed citations
3.
Nakagawa, Kazuhiko, Ernest Nadal, Edward B. Garon, et al.. (2021). RELAY, erlotinib plus ramucirumab or placebo in untreated EGFR-mutated metastatic NSCLC: outcomes by EGFR mutation type. Pneumologie.
4.
Mazières, Julien, Achim Rittmeyer, Shirish M. Gadgeel, et al.. (2020). 1271P 4-year survival in randomised phase II (POPLAR) and phase III (OAK) studies of atezolizumab (atezo) vs docetaxel (doc) in pre-treated NSCLC. Annals of Oncology. 31. S821–S822.
5.
6.
Rittmeyer, Achim, Shirish M. Gadgeel, Marcin Kowanetz, et al.. (2018). Clinical Efficacy of atezolizumab (atezo) in PD-L1 subgroups defined by SP142 and 22C3 IHC assays in 2L+ NSCLC: Results from the randomized OAK study. Pneumologie. 72(S 01). S50–S51. 3 indexed citations
7.
Rittmeyer, Achim, David C. Smith, Johan Vansteenkiste, et al.. (2017). Updated survival and biomarker analyses of a randomized phase II study of atezolizumab vs. docetaxel in 2L/3L NSCLC (POPLAR). Pneumologie. 71(S 01). S1–S125. 4 indexed citations
8.
Schütte, Wolfgang, Fabrice Barlési, K Park, et al.. (2017). Efficacy, safety and predictive biomarker results from OAK, a randomized phase III study comparing atezolizumab with docetaxel in patients with advanced NSCLC. Pneumologie. 71(S 01). S1–S125. 1 indexed citations
9.
10.
Sun, Jong‐Mu, Jung‐Ryul Kim, Iván D. Flórez, et al.. (2013). A phase-1b study of everolimus plus paclitaxel in patients with small-cell lung cancer. British Journal of Cancer. 109(6). 1482–1487. 21 indexed citations
11.
Kim, Yun Joong, Soo‐Mee Bang, Hyuk-Chan Kwon, et al.. (2006). High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases. Bone Marrow Transplantation. 37(9). 819–824. 58 indexed citations
12.
Park, Kye Won, Jung Hun Kang, SH Lee, et al.. (2005). Nasal-type NK/T cell lymphoma: clinical features and treatment outcome. British Journal of Cancer. 92(7). 1226–1230. 72 indexed citations
13.
Paik, Soonmyung, Jennifer Bryant, Elizabeth Tan-Chiu, et al.. (2002). Real-World Performance of HER2 Testing--National Surgical Adjuvant Breast and Bowel Project Experience. JNCI Journal of the National Cancer Institute. 94(11). 852–854. 375 indexed citations
14.
Kim, K, Chul Won Jung, Young‐Hyuck Im, et al.. (2002). Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification. European Journal of Cancer. 38(1). 75–81. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyesil Seol Breakdown of academic impact, for papers by Dara S. Ross Breakdown of academic impact, for papers by Alice E. Guardino Breakdown of academic impact, for papers by Robert B. Jenkins Breakdown of academic impact, for papers by Aude Lamy Breakdown of academic impact, for papers by Anna Cardillo Breakdown of academic impact, for papers by Genevive Hernandez Breakdown of academic impact, for papers by Merdol Ibrahim Breakdown of academic impact, for papers by Antonio Durando Breakdown of academic impact, for papers by Chikako Shimizu
Rankless by CCL
2026